Protease Inhibitor–Based Antiretroviral Prophylaxis during Pregnancy and the Development of Drug Resistance | Zendy

Andrea Gingelmaier | Zendy; Josef Eberle | Zendy; Bernd Kost | Zendy; Johannes R. Bogner | Zendy; Jörg Hofmann | Zendy; Tobias Weissenbacher | Zendy; R Kästner | Zendy; Klaus Friese | Zendy; Katharina Weizsaecker | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Protease Inhibitor–Based Antiretroviral Prophylaxis during Pregnancy and the Development of Drug Resistance

Author(s) -

Andrea Gingelmaier,

Josef Eberle,

Bernd Kost,

Johannes R. Bogner,

Jörg Hofmann,

Tobias Weissenbacher,

R Kästner,

Klaus Friese,

Katharina Weizsaecker

Publication year - 2010

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/650747

Subject(s) - medicine , ritonavir , regimen , protease inhibitor (pharmacology) , reverse transcriptase inhibitor , lopinavir , drug resistance , zidovudine , saquinavir , virology , viral load , pharmacology , immunology , sida , viral disease , virus , antiretroviral therapy , biology , microbiology and biotechnology

The aim of this study was to determine the development of drug resistance among pregnant women receiving a protease inhibitor-based antiretroviral prophylaxis for the prevention of mother-to-child transmission of human immunodeficiency virus (HIV).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research